Mandate

Vinge advises Ambea on its acquisition of Aleris Care

October 16, 2018 Banking and Finance

Vinge has advised Ambea on its acquisition of Aleris’ care operations (“Aleris Care”) from Sirela Sweden AB, which is indirectly owned by Investor through Patricia Industries.

The purchase price amounted to SEK 2.6 billion on a debt free case free basis. Aleris Care is the leader in the private market for care services in Norway, the sixth largest private operator in Sweden and the largest private provider in the Denmark. Today, Ambea is the second largest player in the private market for care services in Sweden and the seventh largest in Norway. Following the acquisition, Ambea will be the largest care provider in the Nordic region with operations in Sweden, Norway and Denmark. The transaction is subject to regulatory approval by the relevant competition authorities and closing is expected to occur during the first quarter of 2019.
 
Vinge’s team consisted of partners Christina Kokko (M&A), Charlotte Levin (Public M&A and Capital Markets), Albert Wållgren (Banking and Finance) and Johan Karlsson (Competition) together with associates Johanna Wiberg, Martin Cronsioe and Karolina Cohrs (M&A), Linn Adelwald, Josefine Lanker and Josefine Larsson (Banking and Finance), Nicklas Thorgerzon, Fredrika Hjelmberg, Hayaat Ibrahim and Victor Berg (Commercial Agreements), Klara Secher (IP), Kristoffer Larson (Real Estate), Sara Strandberg and Lisa Ullman (Employment), Trine Osen Bergqvist, Xandra Ståhlberg and Sofia Landolsi (Competition), Hannes Pettersson (Corporate), Maria Schultzberg, Victor Ericsson and Henrik Wastenson (Tax) and VDR assistant Jessica Öijer. 

Selmer (Norway) and Accura (Denmark) has advised on the transaction’s Norwegian and Danish legal and tax aspects. 
 

Related

Vinge advises in connection with data center provider EcoDataCenter’s tap issue of SEK 500 million bonds

Vinge has advised in connection with EcoDC Holding AB (publ)'s tap issue of SEK 500 million senior unsecured bonds under the existing framework of up to SEK 2 billion.
March 19, 2026

Vinge has advised Cinclus Pharma in connection with entering into financing agreement

Vinge has advised Cinclus Pharma Holding AB (publ), a late-stage clinical pharmaceutical company developing next-generation treatments for gastric acid-related diseases listed on Nasdaq Stockholm, in connection with a long-term structured credit agreement for a total of up to EUR 28 million divided into four tranches, of which two are convertibles.
March 16, 2026

Vinge advises Studentbostäder i Norden AB (publ) in connection with its issuance of bonds in an amount of SEK 500 million and its early redemption of outstanding bonds

Vinge has advised Studentbostäder i Norden AB (publ) in connection with its issuance of senior unsecured bonds in an amount of SEK 500 million (within a framework of SEK 750 million) and in parallel with the company's voluntary early redemption of previously issued bonds.
March 12, 2026